BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32725520)

  • 1. Racial Disparities in Treatment for Rectal Cancer at Minority-Serving Hospitals.
    Lu PW; Scully RE; Fields AC; Welten VM; Lipsitz SR; Trinh QD; Haider A; Weissman JS; Freund KM; Melnitchouk N
    J Gastrointest Surg; 2021 Jul; 25(7):1847-1856. PubMed ID: 32725520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Care at Minority-Serving vs Non-Minority-Serving Hospitals With Use of Palliative Care Among Racial/Ethnic Minorities With Metastatic Cancer in the United States.
    Cole AP; Nguyen DD; Meirkhanov A; Golshan M; Melnitchouk N; Lipsitz SR; Kilbridge KL; Kibel AS; Cooper Z; Weissman J; Trinh QD
    JAMA Netw Open; 2019 Feb; 2(2):e187633. PubMed ID: 30707230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial disparities and standard treatment in locally advanced rectal cancer: a National Cancer Database study.
    Vassantachart A; Marietta M; Mehta S; Lin E; Bian SX
    J Gastrointest Oncol; 2022 Dec; 13(6):2922-2937. PubMed ID: 36636091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparities in NCCN Guideline-Compliant Care for Patients with Early-Stage Pancreatic Adenocarcinoma at Minority-Serving versus Non-Minority-Serving Hospitals.
    Lima HA; Alaimo L; Moazzam Z; Endo Y; Woldesenbet S; Katayama E; Munir MM; Shaikh C; Ruff SM; Dillhoff M; Beane J; Cloyd J; Ejaz A; Resende V; Pawlik TM
    Ann Surg Oncol; 2023 Jul; 30(7):4363-4372. PubMed ID: 36800128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparities in NCCN Guideline Compliant Care for Resectable Cholangiocarcinoma at Minority-Serving Versus Non-Minority-Serving Hospitals.
    Tsilimigras DI; Dalmacy D; Hyer JM; Diaz A; Abbas A; Pawlik TM
    Ann Surg Oncol; 2021 Dec; 28(13):8162-8171. PubMed ID: 34036428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of treatment at minority-serving hospitals on outcomes for bladder cancer.
    Fletcher SA; Gild P; Cole AP; Vetterlein MW; Kibel AS; Choueiri TK; Sonpavde GP; Preston MA; Pucheril D; Menon M; Sun M; Lipsitz SR; Trinh QD
    Urol Oncol; 2018 May; 36(5):238.e7-238.e17. PubMed ID: 29454591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Medicaid Expansion on Receipt of Definitive Treatment and Time to Treatment Initiation by Racial and Ethnic Minorities and at Minority-Serving Hospitals: A Patient-Level and Facility-Level Analysis of Breast, Colon, Lung, and Prostate Cancer.
    Nguyen DD; Paciotti M; Marchese M; Cole AP; Cone EB; Kibel AS; Ortega G; Lipsitz SR; Weissman JS; Trinh QD
    JCO Oncol Pract; 2021 May; 17(5):e654-e665. PubMed ID: 33974827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparities in early-stage lung cancer outcomes at minority-serving hospitals compared with nonminority serving hospitals.
    Deboever N; Correa AM; Feldman H; Mathur U; Hofstetter WL; Mehran RJ; Rice DC; Roth JA; Sepesi B; Swisher SG; Walsh GL; Vaporciyan AA; Antonoff MB; Rajaram R
    J Thorac Cardiovasc Surg; 2024 Jan; 167(1):329-337.e4. PubMed ID: 37116780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disparities in Surgical Treatment of Resectable Pancreatic Adenocarcinoma at Minority Serving Hospitals.
    Olecki EJ; Perez Holguin RA; Mayhew MM; Wong WG; Vining CC; Peng JS; Shen C; Dixon MEB
    J Surg Res; 2024 Feb; 294():160-168. PubMed ID: 37897875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of Care in the Treatment of Localized Intermediate and High Risk Prostate Cancer at Minority Serving Hospitals.
    Krimphove MJ; Fletcher SA; Cole AP; Berg S; Sun M; Lipsitz SR; Mahal BA; Nguyen PL; Choueiri TK; Kibel AS; Kluth LA; Weissman JS; Trinh QD
    J Urol; 2019 Apr; 201(4):735-741. PubMed ID: 30414956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial and Socioeconomic Treatment Disparities in Adolescents and Young Adults with Stage II-III Rectal Cancer.
    Lee DY; Teng A; Pedersen RC; Tavangari FR; Attaluri V; McLemore EC; Stern SL; Bilchik AJ; Goldfarb MR
    Ann Surg Oncol; 2017 Feb; 24(2):311-318. PubMed ID: 27766558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Minority-Serving Hospital Status with Post-Discharge Care Utilization and Expenditures in Gastrointestinal Cancer.
    Lima HA; Woldesenbet S; Moazzam Z; Endo Y; Munir MM; Shaikh C; Rueda BO; Alaimo L; Resende V; Pawlik TM
    Ann Surg Oncol; 2023 Nov; 30(12):7217-7225. PubMed ID: 37605082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment.
    Kaspers M; Llamocca E; Quick A; Dholakia J; Salani R; Felix AS
    Am J Obstet Gynecol; 2020 Sep; 223(3):398.e1-398.e18. PubMed ID: 32142825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparities in clinical trial enrollment among patients with gastrointestinal cancer relative to minority-serving and safety-netting hospitals.
    Khan MMM; Munir MM; Woldesenbet S; Khalil M; Endo Y; Katayama E; Altaf A; Dillhoff M; Obeng-Gyasi S; Pawlik TM
    J Gastrointest Surg; 2024 Jun; 28(6):896-902. PubMed ID: 38555017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the impact of enhanced care at minority-serving hospitals on disparities in the treatment of breast, prostate, lung, and colon cancers.
    Beatrici E; Paciotti M; Nguyen DD; Filipas DK; Qian Z; Lughezzani G; Daniels D; Lipsitz SR; Kibel AS; Cole AP; Trinh QD
    Cancer; 2024 May; ():. PubMed ID: 38798127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparities in surgical 30-day readmission rates for Medicare beneficiaries by race and site of care.
    Tsai TC; Orav EJ; Joynt KE
    Ann Surg; 2014 Jun; 259(6):1086-90. PubMed ID: 24441810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality Disparities in Racial/Ethnic Minority Groups in the Veterans Health Administration: An Evidence Review and Map.
    Peterson K; Anderson J; Boundy E; Ferguson L; McCleery E; Waldrip K
    Am J Public Health; 2018 Mar; 108(3):e1-e11. PubMed ID: 29412713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Access to definitive treatment and survival for intermediate-risk and high-risk prostate cancer at hospital systems serving health disparity populations.
    Nguyen DD; Labban M; Briggs L; Wallis CJD; Cole AP; Lipsitz SR; Iyer HS; Rebbeck TR; Weissman JS; Choueiri TK; Trinh QD
    Urol Oncol; 2023 May; 41(5):252.e9-252.e17. PubMed ID: 36759298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thirty-day readmission rates for Medicare beneficiaries by race and site of care.
    Joynt KE; Orav EJ; Jha AK
    JAMA; 2011 Feb; 305(7):675-81. PubMed ID: 21325183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparities in adjuvant treatment of high-grade endometrial cancer in the Medicare population.
    Corey L; Cote ML; Ruterbusch JJ; Vezina A; Winer I
    Am J Obstet Gynecol; 2022 Apr; 226(4):541.e1-541.e13. PubMed ID: 34736911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.